Showing 21 - 30 of 114
Shares slide on rate worries, weak earnings
Business, Published on 22/01/2022
» Recap: Global shares tumbled yesterday as fears about the pace of monetary policy tightening and weaker-than-expected earnings from Wall Street continued to sour investor confidence.
Unilever Walks Away From Glaxo Consumer-Healthcare Deal
Business, Published on 21/01/2022
» Unilever PLC said it wouldn't increase its $68 billion offer for GlaxoSmithKline PLC's consumer-healthcare business, effectively walking away from a potential deal that would have added a raft of drugstore staples to its portfolio.
Unilever won't up £50bn offer for GSK-Pfizer unit
AFP, Published on 20/01/2022
» LONDON: Consumer goods giant Unilever on Wednesday said it would not increase a £50-billion offer for the consumer healthcare unit owned by pharmaceutical groups GlaxoSmithKline and Pfizer.
Who Invented Covid-19 Vaccines? Drugmakers Battle Over Patents
Business, Published on 31/12/2021
» A high-stakes legal battle is taking shape over lucrative patent rights for Covid-19 vaccines, with drug companies pitted against each other and government and academic scientists over who invented what.
Omicron and Fed tapering depress global outlook
Business, Published on 25/12/2021
» In our previous article published at the end of November, we projected 2022 would be the year of normalisation, with the gradual return of the world economy to reality.
Investors told to buckle up for wild ride on Fed actions
Business, Nuntawun Polkuamdee, Published on 16/12/2021
» The global capital, digital asset and gold markets are likely to face intense volatility in the short term as investors anticipate the Federal Reserve will pursue hawkish monetary policies next year, aiming to curb the spiralling inflation rate that recently hit a 40-year high at 6.8%.
AirAsia CEO 'bullish' on beating Omicron
Janine Phakdeetham, Published on 02/12/2021
» AirAsia Group chief executive Tony Fernandes has urged governments to stop “overreacting” to the emergence of the new Omicron variant of Covid-19 and focus on reducing the cost of PCR testing instead.
Markets hit by Moderna vaccine warning over Omicron
AFP, Published on 30/11/2021
» Equities and oil sank again Tuesday after the head of Moderna warned current coronavirus vaccines might be less effective at fending off the Omicron variant, fuelling fears that countries could be forced back into economically painful lockdowns.
J&J Split Plan Reflects Change in the Healthcare Industry
Business, Published on 15/11/2021
» Johnson & Johnson plans to break up into two companies, splitting off the $15-billion-a-year division that sells Band-Aid bandages, Tylenol medicines and Johnson's Baby Powder in a shift indicating just how much healthcare has changed since the company helped pioneer the industry.
On the Go Again?
Asia focus, Pattama Kuentak, Published on 25/10/2021
» Winter is coming to the northern hemisphere, and people in North America and Europe normally flock to places that offer them a warm-weather break. It's the high season for tourism in many Asian countries, but one that will only happen in a world without Covid-19.